Cargando…
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996376/ https://www.ncbi.nlm.nih.gov/pubmed/35413273 http://dx.doi.org/10.1016/j.ccell.2022.03.010 |
| _version_ | 1784684478460854272 |
|---|---|
| author | Fendler, Annika Shepherd, Scott T.C. Au, Lewis Wilkinson, Katalin A. Wu, Mary Schmitt, Andreas M. Tippu, Zayd Farag, Sheima Rogiers, Aljosja Harvey, Ruth Carlyle, Eleanor Edmonds, Kim Del Rosario, Lyra Lingard, Karla Mangwende, Mary Holt, Lucy Ahmod, Hamid Korteweg, Justine Foley, Tara Barber, Taja Emslie-Henry, Andrea Caulfield-Lynch, Niamh Byrne, Fiona Shum, Benjamin Gerard, Camille L. Deng, Daqi Kjaer, Svend Song, Ok-Ryul Queval, Christophe Kavanagh, Caitlin Wall, Emma C. Carr, Edward J. Namjou, Sina Caidan, Simon Gavrielides, Mike MacRae, James I. Kelly, Gavin Peat, Kema Kelly, Denise Murra, Aida Kelly, Kayleigh O’Flaherty, Molly Shea, Robyn L. Gardner, Gail Murray, Darren Popat, Sanjay Yousaf, Nadia Jhanji, Shaman Van As, Nicholas Young, Kate Furness, Andrew J.S. Pickering, Lisa Beale, Rupert Swanton, Charles Gandhi, Sonia Gamblin, Steve Bauer, David L.V. Kassiotis, George Howell, Michael Nicholson, Emma Walker, Susanna Wilkinson, Robert J. Larkin, James Turajlic, Samra |
| author_facet | Fendler, Annika Shepherd, Scott T.C. Au, Lewis Wilkinson, Katalin A. Wu, Mary Schmitt, Andreas M. Tippu, Zayd Farag, Sheima Rogiers, Aljosja Harvey, Ruth Carlyle, Eleanor Edmonds, Kim Del Rosario, Lyra Lingard, Karla Mangwende, Mary Holt, Lucy Ahmod, Hamid Korteweg, Justine Foley, Tara Barber, Taja Emslie-Henry, Andrea Caulfield-Lynch, Niamh Byrne, Fiona Shum, Benjamin Gerard, Camille L. Deng, Daqi Kjaer, Svend Song, Ok-Ryul Queval, Christophe Kavanagh, Caitlin Wall, Emma C. Carr, Edward J. Namjou, Sina Caidan, Simon Gavrielides, Mike MacRae, James I. Kelly, Gavin Peat, Kema Kelly, Denise Murra, Aida Kelly, Kayleigh O’Flaherty, Molly Shea, Robyn L. Gardner, Gail Murray, Darren Popat, Sanjay Yousaf, Nadia Jhanji, Shaman Van As, Nicholas Young, Kate Furness, Andrew J.S. Pickering, Lisa Beale, Rupert Swanton, Charles Gandhi, Sonia Gamblin, Steve Bauer, David L.V. Kassiotis, George Howell, Michael Nicholson, Emma Walker, Susanna Wilkinson, Robert J. Larkin, James Turajlic, Samra |
| author_sort | Fendler, Annika |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8996376 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89963762022-04-11 Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer Fendler, Annika Shepherd, Scott T.C. Au, Lewis Wilkinson, Katalin A. Wu, Mary Schmitt, Andreas M. Tippu, Zayd Farag, Sheima Rogiers, Aljosja Harvey, Ruth Carlyle, Eleanor Edmonds, Kim Del Rosario, Lyra Lingard, Karla Mangwende, Mary Holt, Lucy Ahmod, Hamid Korteweg, Justine Foley, Tara Barber, Taja Emslie-Henry, Andrea Caulfield-Lynch, Niamh Byrne, Fiona Shum, Benjamin Gerard, Camille L. Deng, Daqi Kjaer, Svend Song, Ok-Ryul Queval, Christophe Kavanagh, Caitlin Wall, Emma C. Carr, Edward J. Namjou, Sina Caidan, Simon Gavrielides, Mike MacRae, James I. Kelly, Gavin Peat, Kema Kelly, Denise Murra, Aida Kelly, Kayleigh O’Flaherty, Molly Shea, Robyn L. Gardner, Gail Murray, Darren Popat, Sanjay Yousaf, Nadia Jhanji, Shaman Van As, Nicholas Young, Kate Furness, Andrew J.S. Pickering, Lisa Beale, Rupert Swanton, Charles Gandhi, Sonia Gamblin, Steve Bauer, David L.V. Kassiotis, George Howell, Michael Nicholson, Emma Walker, Susanna Wilkinson, Robert J. Larkin, James Turajlic, Samra Cancer Cell Correction Elsevier Inc. 2022-04-11 2022-04-11 /pmc/articles/PMC8996376/ /pubmed/35413273 http://dx.doi.org/10.1016/j.ccell.2022.03.010 Text en © 2022 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correction Fendler, Annika Shepherd, Scott T.C. Au, Lewis Wilkinson, Katalin A. Wu, Mary Schmitt, Andreas M. Tippu, Zayd Farag, Sheima Rogiers, Aljosja Harvey, Ruth Carlyle, Eleanor Edmonds, Kim Del Rosario, Lyra Lingard, Karla Mangwende, Mary Holt, Lucy Ahmod, Hamid Korteweg, Justine Foley, Tara Barber, Taja Emslie-Henry, Andrea Caulfield-Lynch, Niamh Byrne, Fiona Shum, Benjamin Gerard, Camille L. Deng, Daqi Kjaer, Svend Song, Ok-Ryul Queval, Christophe Kavanagh, Caitlin Wall, Emma C. Carr, Edward J. Namjou, Sina Caidan, Simon Gavrielides, Mike MacRae, James I. Kelly, Gavin Peat, Kema Kelly, Denise Murra, Aida Kelly, Kayleigh O’Flaherty, Molly Shea, Robyn L. Gardner, Gail Murray, Darren Popat, Sanjay Yousaf, Nadia Jhanji, Shaman Van As, Nicholas Young, Kate Furness, Andrew J.S. Pickering, Lisa Beale, Rupert Swanton, Charles Gandhi, Sonia Gamblin, Steve Bauer, David L.V. Kassiotis, George Howell, Michael Nicholson, Emma Walker, Susanna Wilkinson, Robert J. Larkin, James Turajlic, Samra Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer |
| title | Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer |
| title_full | Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer |
| title_fullStr | Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer |
| title_full_unstemmed | Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer |
| title_short | Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer |
| title_sort | immune responses following third covid-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996376/ https://www.ncbi.nlm.nih.gov/pubmed/35413273 http://dx.doi.org/10.1016/j.ccell.2022.03.010 |
| work_keys_str_mv | AT fendlerannika immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT shepherdscotttc immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT aulewis immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT wilkinsonkatalina immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT wumary immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT schmittandreasm immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT tippuzayd immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT faragsheima immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT rogiersaljosja immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT harveyruth immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT carlyleeleanor immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT edmondskim immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT delrosariolyra immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT lingardkarla immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT mangwendemary immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT holtlucy immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT ahmodhamid immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT kortewegjustine immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT foleytara immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT barbertaja immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT emsliehenryandrea immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT caulfieldlynchniamh immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT byrnefiona immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT shumbenjamin immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT gerardcamillel immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT dengdaqi immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT kjaersvend immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT songokryul immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT quevalchristophe immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT kavanaghcaitlin immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT wallemmac immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT carredwardj immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT namjousina immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT caidansimon immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT gavrielidesmike immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT macraejamesi immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT kellygavin immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT peatkema immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT kellydenise immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT murraaida immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT kellykayleigh immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT oflahertymolly immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT shearobynl immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT gardnergail immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT murraydarren immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT popatsanjay immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT yousafnadia immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT jhanjishaman immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT vanasnicholas immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT youngkate immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT furnessandrewjs immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT pickeringlisa immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT bealerupert immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT swantoncharles immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT gandhisonia immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT gamblinsteve immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT bauerdavidlv immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT kassiotisgeorge immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT howellmichael immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT nicholsonemma immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT walkersusanna immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT wilkinsonrobertj immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT larkinjames immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT turajlicsamra immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer AT immuneresponsesfollowingthirdcovid19vaccinationarereducedinpatientswithhematologicalmalignanciescomparedtopatientswithsolidcancer |